Clinical Trial Update: Estradiol as add-on to Antipsychotics [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating estradiol as an add-on treatment to antipsychotics for schizophrenia-spectrum disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• ESTRADIOL (Estradiol)

Snippet

Sponsor: Tangent Data | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: UNKNOWN